SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    D' Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 70927.
  • 2
    Lomax-Smith JD, Zabrowarny LA, Howarth GS, Seymour AE, Woodroffe AJ. The immunochemical characterisation of mesangial IgA deposits. Am J Pathol 1983; 113: 35964.
  • 3
    Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 1980; 66: 14326.
  • 4
    Bene M-C, Faure G, Duheille J. IgA nephropathy: characterisation of the polymeric nature of mesangial deposits by in vitro binding of free secretory component. Clin Exp Immunol 1982; 47: 52734.
  • 5
    Tomino Y, Sakai H, Miura M, Endoh M, Nomoto Y, Kobayashi K. Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. Clin Exp Immunol 1982; 49: 41925.
  • 6
    Monteiro RC, Halbwachs-Mecherelli L, Roque-Barreira MC, Noel LH, Berger J, Lesavre P. Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 1985; 28: 66671.
  • 7
    Muso E, Yoshida H, Takeuchi E, Shimida T, Yashiro M, Sugiyama T, Kawai C. Pathogenic role of polyclonal and polymeric IgA in a murine model of mesangial proliferative glomerulonephritis with IgA deposition. Clin Exp Immunol 1991; 84: 45965.
  • 8
    Heremans JE, Immunoglobulin A. In: SelaM. ed. The antigens. Vol. 2. New York : Academic Press. 1974;365552.
  • 9
    Delacroix DL, Elkon AB, Geubel AP, Hodgson HF, Dive C, Vaerman JP. Changes in size, subclass and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest 1983; 71: 35867.
  • 10
    Jones CL, Powell HR, Kincaid-Smith P, Roberton DM. Polymeric IgA and immune complex concentrations in IgA related renal disease. Kidney Int 1990; 38: 32331.
  • 11
    Feehally J, Beattie TJ, Brenchley PEC, Coupes BM, Mallick NP, Postlethwaite RJ. Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int 1986; 30: 92431.
  • 12
    Van Den Wall Bake AWL, Daha MR, Radl J, Haaijman JJ, Van Der Ark A, Valentijn RM, Van Es LA. The bone marrow as the production site of the IgA deposited in the kidneys of patients with IgA nephropathy. Clin Exp Immunol 1988; 72: 3215.
  • 13
    Van Den Wall Bake AWL, Daha MR, Van Der Ark A, Heimstra PS, Radl J, Van Es LA. Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy. Clin Exp lmmunol 1988; 74: 115120.
  • 14
    Feehally J. Immune mechanisms in glomerular IgA deposition. Nephrol Dial Transp 1988; 3: 36178.
  • 15
    Egido J, Blasco R, Sanchi J, Lozano L, Sanchcz-Crespo M, Hernando L. Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis. Clin Exp Immunol 1982; 47: 30916.
  • 16
    Lozano L, Garcia-Hoya R, Edigo J. IgA nephropathy: association of a history of macroscopic hematuria episodes with increased production of polymeric IgA. Nephron 1987; 45: 98103.
  • 17
    Endoh M, Suga T, Miura M, Tomino J, Nomoto Y, Sakai H. In vivo alteration of antibody production in patients with IgA nephropathy. Clin Exp Immunol 1984; 57: 56470.
  • 18
    Pasternack A, Mustonen J, Leinikki P. Humoral immune response in patients with IgA and IgM glomerulonephritis. Clin Exp Immunol 1986; 63: 22833.
  • 19
    Layward L, Allen AC, Finnemore AM, Harper SJ, Feehally J. Evidence for a shift from IgG to IgA production in IgA nephropathy. Nephrol Dial Transp 1990; 5: 680 (Abstract).
  • 20
    Leinikki PO, Mustonen J, Pasternack A. Immune response to oral polio vaccine in patients with IgA glomerulonephritis. Clin Exp Immunol 1987; 68: 338.
  • 21
    Van Den Wall Bake AWL, Beyer WEP, Evers-Schouten JA, Hermans J, Dahja MR, Masurel N, Van Es LA. Humoral immune response to Influenza vaccination in patients with primary immunoglobulin A nephropathy. J Clin Invest 1989; 84: 10705.
  • 22
    Mascart-Lemone F, Duchaleau J, Conley ME, Delacroix DL. A polymeric IgA response in serum can be produced by parenteral immunisation. Immunology 1987; 61: 40913.
  • 23
    Harper SJ, Pringle JH, Wicks ACB, Lauder I, Feehally J. Simultaneous in situ hybridization of J chain mRNA and conventional immunofluorescence in cells of the lamina propria in IgA nephropathy. J Am Soc Nephrol 1991; 2: 543 (Abstract).
  • 24
    Czerkinsky C, Koopman WJ, Jackson S. et al. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest 1986; 77: 19318.
  • 25
    Kutteh WH, Prince SJ, Mestecky J. Tissue origins of human polymeric and monomeric IgA. J Immunol 1982; 128: 9905.
  • 26
    Rifai A, Schcna P, Montinaro V, Mele M, D'Addabbo A, Nitti L, Pezzullo JC. Clearance kinetics and fate of macromolecular IgA in patients with IgA nophropathy. Lab Invest 1989; 61: 3818.
  • 27
    Andre PM, Le Pogamp P, Chevet D. Impairment of jacalin binding to serum IgA in IgA Nephropathy. J Clin Lab Anal 1990;4: 11519.
  • 28
    Lesavre PH, Digeon M, Bach JF. Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin Exp Immunol 1982; 48: 619.
  • 29
    Conley ME, Delacroix DL. Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defence. Ann Intern Med 1987; 106: 8929.
  • 30
    Alley CD, Kiyono H, McGhee JR. Murine bone marrow IgA responses to orally administered sheep erythrocytes. J Immunol 1986; 136: 44149.